Literature DB >> 28468863

Hey Factors at the Crossroad of Tumorigenesis and Clinical Therapeutic Modulation of Hey for Anticancer Treatment.

Zihao Liu1, Andrew J Sanders2, Gehao Liang1, Erwei Song1, Wen G Jiang3, Chang Gong4,2.   

Abstract

Hairy and Enhancer-of-split related with YRPW motif (Hey) transcription factors are important regulators of stem cell embryogenesis. Clinical relevance shows that they are also highly expressed in malignant carcinoma. Recent studies have highlighted functions for the Hey factors in tumor metastasis, the maintenance of cancer cell self-renewal, as well as proliferation and the promotion of tumor angiogenesis. Pathways that regulate Hey gene expression, such as Notch and TGFβ signaling, are frequently aberrant in numerous cancers. In addition, Hey factors control downstream targets via recruitment of histone deacetylases (HDAC). Targeting these signaling pathways or HDACs may reverse tumor progression and provide clinical benefit for cancer patients. Thus, some small molecular inhibitors or monoclonal antibodies of each of these signaling pathways have been studied in clinical trials. This review focuses on the involvement of Hey proteins in malignant carcinoma progression and provides valuable therapeutic information for anticancer treatment. Mol Cancer Ther; 16(5); 775-86. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28468863     DOI: 10.1158/1535-7163.MCT-16-0576

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  5 in total

1.  Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non-neuroendocrine Small Cell Lung Cancer.

Authors:  Atsushi Fushimi; Yoshihiro Morimoto; Satoshi Ishikawa; Nami Yamashita; Atrayee Bhattacharya; Tatsuaki Daimon; Hasan Rajabi; Caining Jin; Masayuki Hagiwara; Yota Yasumizu; Zhou Luan; Wenhao Suo; Kwok-Kin Wong; Henry Withers; Song Liu; Mark D Long; Donald Kufe
Journal:  Mol Cancer Res       Date:  2022-09-02       Impact factor: 6.333

2.  Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy.

Authors:  Mohammad Fereydouni; Elnaz Ahani; Parth Desai; Mona Motaghed; Anthony Dellinger; Dean D Metcalfe; Yuzhi Yin; Sung Hyun Lee; Tal Kafri; Aadra P Bhatt; Kristen Dellinger; Christopher L Kepley
Journal:  Front Oncol       Date:  2022-04-22       Impact factor: 5.738

3.  MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells.

Authors:  Masayuki Hagiwara; Yota Yasumizu; Nami Yamashita; Hasan Rajabi; Atsushi Fushimi; Mark D Long; Wei Li; Atrayee Bhattacharya; Rehan Ahmad; Mototsugu Oya; Song Liu; Donald Kufe
Journal:  Cancer Res       Date:  2020-12-15       Impact factor: 13.312

4.  Complementary effects of Orthosiphon stamineus standardized ethanolic extract and rosmarinic acid in combination with gemcitabine on pancreatic cancer.

Authors:  Ashwaq H S Yehya; Muhammad Asif; Amin M S Abdul Majid; Chern E Oon
Journal:  Biomed J       Date:  2020-05-28       Impact factor: 4.910

5.  Longevity strategies in response to light in the reef coral Stylophora pistillata.

Authors:  Alexandre Ottaviani; Rita Eid; Didier Zoccola; Mélanie Pousse; Jean-Marc Dubal; Edwige Barajas; Karine Jamet; Kevin Lebrigand; Pascal Lapébie; Christian Baudoin; Marie-Josèphe Giraud-Panis; Alice Rouan; Gallic Beauchef; Christelle Guéré; Katell Vié; Pascal Barbry; Sylvie Tambutté; Eric Gilson; Denis Allemand
Journal:  Sci Rep       Date:  2020-11-17       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.